The Morning Blend



Posted at 10:38 AM, Jul 27, 2020
and last updated 2020-07-27 10:38:30-04


Dr. Hauser is Director of the Signature Interdisciplinary Clinical Research Program in Neuroscience at the University of South Florida. He is Past Chairman of the Interventional Neurology Section of the American Academy of Neurology and previously served on the executive committee of the Section of Movement Disorders. He is currently a member of the executive committee of the Parkinson Study Group and the steering committee of the NIH Exploratory Trials in Parkinson’s Disease (NET-PD) program. Dr. Hauser has authored or co-authored over 100 peer reviewed publications. He currently serves as lead investigator or as a member of the steering committee for multiple national and international clinical trials. He lectures frequently at scientific meetings and has been selected to Chair the 18th International Congress on Parkinson’s Disease and Related Disorders in Miami, Florida in 2009. Dr. Hauser is a paid consultant to ACADIA Pharmaceuticals.


With more than 25 years of experience leading non-profits and healthcare programs, Sarah is the CEO of the Parkinson & Movement Disorder Alliance. Previously, Sarah designed programs and led training for local, national and international audiences, including groups in Canada and Botswana. She holds two Master’s degrees: Master’s of Science in Strategic Design Management and a Master’s in Public Administration.

Interview provided by: ACADIA Pharmaceuticals